The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis. H在 之前，我们来总结一下 上个月来自 的头条新闻。 

Want arthritis news daily? You’re in luck. Coming this summer, important news that affects you will be found online — so you won’t have to wait for a monthly email to learn about the latest advancements in treatments, the newest study findings, important COVID updates and more. Stay tuned for our launch announcement coming soon.

The Latest in COVID-19 News & Arthritis

FDA Approves COVID Booster for Ages 5-11

FDA修订了辉瑞- biontech COVID-19疫苗的紧急使用授权，授权5至11岁的个人使用单一加强剂。Learn more.

Know Your COVID-19 Community Level

The CDC recently unveiled COVID-19 Community Levels, a tool to help communities decide what prevention steps to take based on the latest data. Levels can be low, medium or high and are determined by looking at hospital beds being used, hospital admissions and the total number of new COVID-19 cases in an area.Check your community level.

Quarantine & Isolation Calculator FAQ

获取最新的CDC工具，以帮助确定隔离、隔离或采取其他步骤所需的时间，以防止COVID-19传播。Try the tool.

获取针对关节炎患者的最新COVID-19指南。Visit ourCare & Connect pageto find the latest coronavirus information.

In Other Arthritis News

Healthy-Appearing Lupus Skin Predisposed to Flares, Rashes

In patients with lupus, a new study finds that the normal-appearing skin of lupus patients contains the same inflammatory signals that are detected when the skin develops a rash, sometimes at even higher levels.Read more.

Rising Incidence of Lupus

A new study has found the incidence and prevalence of systemic lupus erythematosus are increasing.Learn more about the study findings.

患有狼疮等慢性疾病会对你的情绪健康造成损害。学习如何建立一个更好的自我形象，开始对自己的身体感觉良好。Read more.

Infection Risks Similar With TNFi and cDMARDs Plus MTX

According to study results published inSeminars in Arthritis & Rheumatology,在伴有甲氨蝶呤治疗的类风湿关节炎(RA)患者中，来氟米特和肿瘤坏死因子抑制剂(TNFis)与他克莫司和TNFis之间发生严重感染的风险没有差异。Learn more.

Healthy Lifestyle Modifications May Lower Risk of Genetically Induced Gout

While genetics are linked to gout diagnosis and lifestyle factors are related to risk, a healthy lifestyle was associated with a lower risk of gout, mitigating risk related to genetic factors by almost a third, according to a study published inBMC Medicine.Find out more about this study.

学习与痛风的健康生活方式的做和不要。找出哪些食物是最好的，哪些应该避免来预防耀斑。Learn more.

Less Frequent Methotrexate Monitoring May Be Safe

Reducing the frequency of routine blood monitoring for methotrexate in patients with rheumatoid arthritis during the COVID-19 pandemic was associated with no adverse outcomes for patients.Read more.

Methotrexate is one of the most commonly prescribed arthritis medicines.Learn what to expect if you take it.

This Arthritis Awareness Month, look out for Arthritis Foundation billboards in select cities across the U.S. as we work to raise awareness about arthritis and the nearly 60 million people it affects.Journey with usto find the resources and support you need to thrive.

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis. H在 之前，我们来总结一下 上个月来自 的头条新闻。 

The Latest in COVID-19 News & Arthritis

White House Says COVID Treatment Paxlovid Going Nationwide

随着病例的增加，白宫正在扩大对Paxlovid的获取和使用，这是一种由辉瑞公司生产的药物，用于治疗12岁及以上感染COVID-19并有严重疾病高风险的人。帕克斯洛维德被发现可以将与covid相关的住院风险降低90%。Learn more.

Fauci Clarifies ‘Out of the Pandemic Phase’ Comment

As the nation’s top infectious disease expert, what Anthony Fauci, MD, says carries considerable weight, and his statement that the U.S. was “out of the pandemic phase” made national headlines. But a day later, Fauci clarified his comments — saying the country is not out of the pandemic, but “out of the full-blown explosive pandemic phase.”Read more.

Know Your COVID-19 Community Level

The CDC recently unveiled COVID-19 Community Levels, a tool to help communities decide what prevention steps to take based on the latest data. Levels can be low, medium or high and are determined by looking at hospital beds being used, hospital admissions and the total number of new COVID-19 cases in an area.Check your Community Level.

Quarantine & Isolation Calculator FAQ

获取最新的CDC工具，以帮助确定隔离、隔离或采取其他步骤所需的时间，以防止COVID-19传播。Try the tool.

获取针对关节炎患者的最新COVID-19指南。Visit ourCare & Connect pageto find the latest coronavirus information.

In Other Arthritis News

This Arthritis Awareness Month, we journey together.Find the resources and support你需要茁壮成长。

Mixed Feelings After Joint Replacement

While most osteoarthritis patients welcome the pain relief that comes with total knee replacement, some also experience psychological impacts that aren’t so pleasant.阅读这些病人的经历。

Is it time for joint replacement? Tune in to our expert Q&A to hear an orthopedic surgeon share advice on when to get joint replacement surgery.Watch now.

Insights on Overall & Cardiovascular-Specific Mortality in AS & PsA

People with ankylosing spondylitis — but not those with psoriatic arthritis — face a significantly increased risk of overall mortality, results of a new analysis show. However, rates of cardiovascular mortality were higher for both conditions compared with the general population.Read the findings.

One Benefit We Don’t See From RA Biologics

一名政府研究人员发现，2015年，美国与类风湿性关节炎相关的残疾申请与1999年一样普遍，与生物疗法的出现会导致类风湿性关节炎数量稳步下降的预期相反。Read more.

Opioid Distributors Reach Settlement With Washington State

华盛顿与药品分销商McKesson Corp、AmerisourceBergen Corp和Cardinal Health Inc.达成了5.18亿美元的和解协议，结束了围绕这些公司涉嫌助长该州阿片类药物泛滥的长达数月的审判。Learn moreabout the settlement.

Benefits of reducing or stopping opioids outweigh the downsides.Click here寻求停止阿片类药物的专家建议。

FDA Approves New Drug for Adults With Ankylosing Spondylitis

The FDA has approved once-daily, oral upadacitinib (Rinvoq, AbbVie) for the treatment of adults with active ankylosing spondylitis. The FDA approval follows recent efficacy and safety data from two trials, which found that upadacitinib demonstrated rapid and meaningful disease control among adults with AS.Read moreabout the approval.

了解关于治疗强直性脊柱炎的事实。Visit our AS treatment pagefor more information.

RAPID3 Questionnaire May Reduce Outpatient Visits in Patients With RA

根据一项新的研究，常规评估患者指数数据3 (RAPID3)在识别类风湿关节炎(RA)患者的低疾病活动性方面有92%的准确率，从而减少了28%的现场评估。Learn more.

Celiac Disease More Prevalent in Patients With Juvenile Idiopathic Arthritis

According to a study published inPediatric Rheumatology, ahigher percentage of celiac disease was reported in a large juvenile idiopathic arthritis cohort in Italy, which supports the need for screening in this patient population, especially for those with a family history of autoimmunity.Read more.

麸质和关节炎之间有联系吗?如果你有乳糜泻或麸质敏感，改变你的饮食可能有助于缓解关节炎症状。学习的原因.

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.Here’s a wrap-up of the headlines from this past month. 

The Latest in COVID-19 News & Arthritis

Know Your COVID-19 Community Level

The CDC recently unveiled COVID-19 Community Levels, a tool to help communities decide what prevention steps to take based on the latest data. Levels can be low, medium or high and are determined by looking at hospital beds being used, hospital admissions and the total number of new COVID-19 cases in an area.Check your Community Level.

Omicron Leads to More Children Under 5 Hospitalized

Young children in the United States were hospitalizedat much higher rates last winter as omicron became the dominant variant, according to a疾控中心发布的新报告。Read more.

COVID-19 Vaccines Effective in Young Patients With Rheumatic Diseases

A two-dose regimen of COVID-19 mRNA vaccines elicited a robust humoral neutralization response in almost all adolescents and young adults with childhood-onset rheumatic diseases in a new study from Singapore.Read about the study.

CDC Outlines Treatment Options for Coronavirus Patients

Guidance from the CDC now explains best practices for health care professionals treating COVID-19 patients.Learn more about these guidelines.

获取针对关节炎患者的最新COVID-19指南。Visit ourCare & Connect pageto find the latest coronavirus information.

In Other Arthritis News

Sleep Apnea Linked to Joint Pain in Postmenopausal Women

Sleep apnea may lead to increased joint pain in postmenopausal women, according to a study published online.Read the study.

Does arthritis impact your quality of sleep?Get expert sleep tips所以你可以休息得更健康，即使是在疼痛发作的时候。

RA Patients Impacted by Weight Changes

According to study results published inArthritis Care and Research, w8个波动可以预测风湿性关节炎患者心血管风险的升高——特别是在较瘦的患者中，他们可能在这个问题上被忽视。Learn more.

Predicting Whether AS Patients Will Respond to Anti-TNFs

研究人员在一项建模研究中报告称，仅根据一项标准实验室测试和两项疾病活动度指标，对强直性脊柱炎患者使用TNF抑制剂治疗是否会显著改善的预测具有中等到较高的准确性。Read more about the study.

Steroid Injections as Safe as HA Shots for Knee OA

Corticosteroid injections are just as safe as hyaluronic acid injections in people with OA of the knee, study findings show.Learn more.

了解更多关于类固醇注射的知识。Watch an expert Q&A这涵盖了关于这种治疗的最常见问题。

Knee Replacements in Patients Over 80

According toone study presented at the 2022 Annual Meeting of theAmerican Academy of Orthopaedic Surgeons, total knee arthroplasty in patients over 80 years old have lower levels of implant-related complications, but higher readmission rates, medical complications and length of stays.Read more.

Updated Perioperative Guidance on Antirheumatics

美国风湿病学会(American College of Rheumatology)和美国髋关节和膝关节外科医生协会(American Association of Hip and Knee Surgeons)发布了最新的指南，关于是否对计划接受选择性全髋关节或膝关节置换手术的炎症性风湿病患者停用生物制剂和免疫抑制剂等药物。Learn more.

Disease-modifying antirheumatic drugs (DMARDs) stop or slow the disease process in inflammatory forms of arthritis.Learn more about this type of medication.

Debate on Definition of Flare in Axial Spondyloarthritis

在实践中，如何最好地定义轴性脊椎关节炎耀斑仍然是一些争论的主题，这在第12届国际脊椎关节炎大会上的一个抽象报告之后的讨论中得到了证明。Read more.

Choosing Initial PsA Treatment

For patients withpsoriatic arthritiswhose condition doesn’t respond adequately tomethotrexate, the addition of the TNF inhibitoradalimumabincreased the likelihood of achieving minimum disease activity, according to results from a phase 4, open-label study.Learn more.

One-Third of PsA Patients Could Have Metabolic Syndrome

代谢综合征的患病率因其定义而异，但在一项724人的队列研究中，约30%的银屑病关节炎患者符合标准，在多项研究中约23%至63%的患者符合标准，来自西班牙的研究人员报告说。Read more.

Do you have questions about PsA treatments?Learn moreabout the various psoriatic arthritis treatment options recommended by experts.

Trial Findings Question Need for Prehabilitation Before Total Knee Replacement

在这项有262名参与者参与的随机临床试验中，膝关节骨关节炎全膝关节置换术前的多学科康复治疗并没有改善术后短期功能独立性或减少术后中期活动限制。Learn more.

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.Here’s a wrap-up of the headlines from this past month. 

The Latest in COVID-19 News & Arthritis

Updated Guidance for Vaccination in Rheumatology Patients

在风湿病学家努力应对某些亚群患者对疫苗接种的犹豫之际，美国风湿病学会发布了针对风湿病和肌肉骨骼疾病患者的COVID-19疫苗接种最新临床指南，包括关于补充和加强剂量的新建议。Read more.

通过访问关节炎基金会的关爱与联系门户网站，获取关于COVID-19的最新信息和新闻。

FDA Delays Action on Pfizer Vaccine for Kids Under 5

美国食品药品监督管理局表示，在获得三剂疫苗效果的数据之前，将推迟决定是否批准在低龄儿童中使用辉瑞公司的疫苗。Learn more.

FDA Considers Second COVID-19 Booster Shot

FDA已经开始审查数据，可能批准辉瑞和Moderna的第四剂COVID-19疫苗在秋季上市。批准将取决于正在进行的研究，这些研究必须表明，第四剂将增加逐渐减弱的免疫力，并减少严重疾病的风险。Read the story.

CDC Urges Extra Precautions for People与Certain Medical Conditions

The CDC recently updated its guidance for people with certain medical conditions and those who are immunocompromised.Get the latest suggestions from the CDC.

FDAOkaysNew Monoclonal Antibody Effective Against Omicron

The FDA authorized Eli Lilly’s COVID-19 antibody drug for people aged 12 and older at risk of severe illness, adding a tool that has been found to work against the highly contagious Omicron variant.Learn more about the treatment.

COVID-19 Vaccines Safe, Effective in Rheumatic Diseases

The European Alliance of Associations for Rheumatology Coronavirus Vaccine registry has shown that vaccination against SARS-CoV-2 provides people with inflammatory or noninflammatory rheumatic and musculoskeletal disease similar levels of protection with a similar adverse event profile as the general public.Read more about the findings.

Get answers to the most common COVID-19 questions for people with arthritis.

In Other Arthritis News

CDC Releases Updated Draft Guidance on Opioid Prescribing

The CDC has released a draft update of its current Clinical Practice Guidelines for Prescribing Opioids for pain management and is asking for public comment before moving forward.Read the new draft update.

今天下载Vim应用程序，你会发现大量的资源和支持，你需要它们来管理你的痛苦。

Dietary Recommendations for Inflammatory Rheumatic Diseases

Jérémie来自巴黎圣安东尼医院的Sellam医学博士总结了法国风湿病学会第一组饮食建议的要点。
Read the recommendations.

Find out how the Ultimate Arthritis Diet could help your joints feel better.

Multiple Sleep Problems May Boost Heart Disease Risk by More Than 140%

New research shows that having more than one sleep problem increased an individual’s risk of heart disease by up to 141% in a retrospective analysis.Learn more about this study.

Physical Activity Impacts Quality of Life for People With Inflammatory Arthritis

According to a lit review published recently inArthritis Care & Research, p运动可以改善类风湿关节炎(RA)、脊椎关节炎(SpA)和银屑病关节炎(PsA)患者的生活质量和自我报告功能。Read the review.

Get active without hurting your joints. Try the YES (Your Exercise Solution) tool to find movements based on your specific needs and ability level — with modifications developed and approved by physical therapists.Try YES today.

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.Here’s a wrap-up of the headlines from this past month. 

The Latest in COVID-19 News & Arthritis

Arthritis Drugs May Reduce COVID-19 Vaccine Effectiveness

According to limited research, evidence suggests that disease-modifying drugs used for arthritis may reduce the response of the mRNA COVID-19 vaccines from Pfizer and Moderna.Read more.

Booster Shots Strongly Protect Against Severe Disease From Omicron Variant

Vaccine boosters provide robust protection against severe disease from the omicron variant in the United States, according to three reports that use real-world data to show the shots are effective at keeping vaccinated people out of the hospital.Learn more.

欧米克隆热潮在美国达到顶峰了吗?

Some experts believe COVID-19 cases are finally falling in the United States, welcome news after nearly two months of skyrocketing case counts driven by the highly infectious omicron variant.Find out more.

U.S. Starts Shipping Free COVID-19 Tests Amid Omicron

The U.S. Postal Service has begun shipping free at-home rapid COVID-19 tests after millions of orders were placed through a new federal website launched last week.Learn more.

Immune Dysfunction Linked to Risk of Breakthrough COVID-19 Infection

Although vaccines reduce the overall risk for COVID-19, regardless of immune status, patients with immune dysfunction are at a substantial risk for breakthrough infection versus those without, according to data.Read more.

Association Between Three Doses of COVID-19 Vaccine and Symptomatic Infection

Findings suggest that vaccination with three doses of mRNA COVID-19 vaccine, compared with being unvaccinated and with receipt of 2 doses, was associated with protection against both the omicron and delta variants.Read the report.

Patients Taking Rituximab Show Negligible Antibody Response to COVID-19 Vaccines

anca相关血管炎(AAV)患者在标准的两剂辉瑞生物技术疫苗方案后，对delta变体没有产生持久的抗体反应——对于那些使用利妥昔单抗(利妥昔an)作为维持治疗的患者，即使是第三剂也没有多大帮助。Learn more.

In Other Arthritis News

Antidepressant for Osteoarthritis Doesn’t Meet Expectations

Previous studies had shown that the antidepressant drug duloxetine (Cymbalta) helped relieve pain in OA patients, leading to recommendations that it be part of the clinical toolkit. But now comes a new trial questioning the benefit in real-world settings.Read the study.

Ankylosing Spondylitis Patients Don’t Always Fit the Mold

Even for a stereotypical patient, ankylosing spondylitis can take years to get diagnosed. If, like Christi Taylor-Gentry, you’re seen as an anomaly, the delay can be even more extreme.Read her story.

A Statistician Explores Painfully Weak Evidence for Collagen

“My knees aren’t nearly bad enough for surgery, but I’ve tried most everything else. A steroid injection provided relief, but only for a week. Physical therapy worked when I did the exercises religiously, but I’d lapsed in recent months. So, I thought I might try collagen supplements.”Learn more.

FDA Approves Risankizumab (Skyrizi) for Psoriatic Arthritis

The FDA approved risankizumab-rzaa (Skyrizi) for a second indication — treating adults with active psoriatic arthritis — making it the second anti-interleukin 23 monoclonal antibody available to treat PsA.Read the announcement.

Hip OA Burden Increasing in Almost All Countries

The burden of hip osteoarthritis has increased globally in the past 30 years, with incidence and disability-adjusted life years rising in nearly all countries, according to data published inArthritis Research & Therapy.Learn more.

Machine Learning IDs Predictors of Treatment Response in RA

Machine learning, integrating clinical and genomic data, can be used to predict methotrexate treatment response in early rheumatoid arthritis, according to a study published inArthritis Care & Research.Read the study.

University of Michigan Survey Seeks Input From Arthritis Patients Using Cannabis Products To Manage Pain

你是否使用CBD或其他医用大麻产品来控制关节炎疼痛?与研究人员分享你的经验。Take the survey.

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.Here’s a wrap-up of the headlines from this past month. 

The Latest in COVID-19 News & Arthritis

Omicron Surge Brings Highest Rate of Coronavirus Cases

随着高传染性欧微米变异病毒在全国继续激增，美国报告了自大流行开始以来新冠病毒平均7天感染人数的最高水平。Read more.

COVID Antiviral Drugs Are Here, Remain Scarce

Pfizer’s Paxlovid and Merck’s molnupiravir are both oral antiviral pills that can be taken at home to keep patients out of the hospital. They’re meant to be taken within the first few days of having COVID-19, and they reduce the risk of hospitalization and death by up to 88% for Paxlovid and 30% for molnupiravir. Supply is tight, and the rollout varies from state to state.Learn more.

CDC Recommends Pfizer, Moderna Vaccines Over J&J’s

The Centers for Disease Control and Prevention changed its recommendations for Covid-19 vaccines to make clear that shots made by Moderna and Pfizer/BioNTech are preferred over Johnson & Johnson’s vaccine.学习的原因.

COVID Vaccine Booster Recommended for Teens

Health officials authorized booster shots for 16- and 17-year-olds in response to an increase in COVID-19 cases, along with concerns about upcoming winter months.Read more.

FDA Plans to Allow 12- to 15-Year-Olds to Receive Pfizer Boosters

美国食品和药物管理局正计划扩大新冠病毒疫苗加强注射的资格，允许12至15岁的儿童接种第三剂辉瑞生物科技公司的疫苗。Learn more.

In Other Arthritis News

FDA Adds Strict Safety Warnings on Arthritis Drugs

The FDA has added its strictest warning to the labels of drugs from Pfizer, Eli Lilly and AbbVie belonging to a class of anti-inflammatory treatments called JAK inhibitors, citing risk of serious health issues and death in patients 50 and over.Read more.

First JAK Inhibitor OK’d for Ankylosing Spondylitis

The FDA approved tofacitinib (Xeljanz, Xeljanz XR) for treating active ankylosing spondylitis in adults. Tofacitinib is the first JAK inhibitor approved for ankylosing spondylitis.Learn more.

Upadacitinib (Rinvoq) Gains Psoriatic Arthritis as Second FDA-Approved Indication

The FDA has approved a 15-mg extended-release tablet of upadacitinib (Rinvoq) for adults with psoriatic arthritis who had an inadequate response or intolerance to one or more anti-tumor necrosis factor drugs. The approval is the second indication given by the agency for the selective JAK inhibitor upadacitinib, which was previously approved for rheumatoid arthritis (RA) in 2019.Find out more.

AbbVie Updates Upadacitinib Prescription Guidelines Amidst Safety Concerns

AbbVie recently announced an amendment to its prescribing Information for upadacitinib. The drug, a selective JAK inhibitor, now states that it is intended for adults with moderate-to-severe rheumatoid arthritis who have had inadequate response or intolerance to at least one TNF blocker.Read more.

Mayo Clinic Researchers Use AI, Biomarkers to Personalize RA Treatment

Treatment options for rheumatoid arthritis have often relied on trial and error. Now Mayo Clinic researchers are exploring the use of artificial intelligence and pharmacogenomics to predict how patients will respond to treatments, and to personalize care.Learn more.

The Arthritis Foundation is your trusted source for arthritis-related news and COVID updates that affect people with arthritis.Here’s a wrap-up of the headlines from this past month. 

American College of Rheumatology Research Highlights

The 2021 American College of Rheumatology (ACR) Convergence conference was recently held, gathering researchers, clinicians and patients alike for a week of knowledge sharing to advance treatments, understanding and approaches to managing various rheumatic diseases.Read the highlights.

Listento the Live Yes! With Arthritis podcast episode showcasing all the exciting news from the 2021 ACR Convergence conference.

The Latest in COVID-19 News & Arthritis

COVID Vaccine Booster Approved for All Adults

卫生官员授权为所有美国成年人注射加强疫苗，以应对COVID-19病例的增加，以及对即将到来的假期和冬季的担忧。Learn moreabout COVID vaccine boosters.

Mask-Wearing Cuts New COVID-19 Cases by Half

When people wear face masks to reduce the spread of the coronavirus, the number of new COVID-19 infections drops by 53%, according to anew study发表在《英国医学杂志》上Read moreabout this study.

Scientists Race to Find Out if Vaccines Stop Omicron

Amid fears of another global surge of the coronavirus, scientists are scrambling to gather data on the new omicron variant, its capabilities and — perhaps most important — how effectively the current vaccines will protect against it.Read moreabout the omicron variant.

In Other Arthritis News

Serious Infection Hospitalizations Have Declined in Patients With PsA

从2012年到2017年，美国银屑病关节炎(PsA)患者因三种严重感染住院的比率似乎有所下降。Learn more关于这些发现。

Diagnosed with psoriatic arthritis?Check out our PsA portalto find out what you need to know to take control.

Long-term Glucocorticoids in RA Linked to Increased Cardiovascular Risk

美国退伍军人管理局(Veterans Administration)的一项研究显示，中年类风湿性关节炎患者每月使用糖皮质激素，发生重大心脏不良事件的几率会增加14%，与基线心血管风险无关。Read more.

Allopurinol Proves Noninferior to Febuxostat for Gout Relief

Allopurinol may finally start to get the respect that many rheumatologists feel it deserves as a first-line, urate-lowering treatment for gout, following results of a randomized trial showing that it was noninferior to febuxostat both in the overall trial population and in patients with stage 3 chronic kidney disease.Learn moreabout this study.

Find out how to live well with gout.View our gout webinar, led by renowned experts,

获取有关病因、症状、缓解和伴随条件的信息。

Vitamin D and Omega-3 Supplements Reduce Autoimmune Disease Risk

Among nearly 26,000 adults enrolled in a randomized trial, five years of vitamin D supplementation was associated with a 22% reduction in risk for confirmed autoimmune diseases, and five years of omega-3 fatty acid supplementation was associated with an 18% reduction in confirmed and probable incident autoimmune diseases.Read more关于这些发现。